Dimension Inx, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Dimension Inx, LLC - overview
Established
2017
Location
Chicago, IL, US
Primary Industry
Biotechnology
About
Based in Illinois, US, and founded in 2017, Dimension Inx, LLC designs and develops bioactive therapeutic products that restore tissue and organ function. In January 2023, the firm raised USD 12 million in series A funding led by investor Prime Movers Lab, with participation from investors KdT Ventures and Revolution Ventures. The company through its biomaterials and manufacturing process develops and manufactures 3D-printed bioactive structures to drive bifunctionality and to treat human disease and debilitation including musculoskeletal health, and reproductive health. The company’s material provides a three-dimensional blueprint, that directs cells to behave as intended in bone regeneration, reproductive longevity, etc.
Dimensions also work on the development of new materials for tissue therapeutics such as soft tissue restoration, and cell therapy delivery. The business intends to use its January 2023 fundraising to advance therapeutic development as well as scale the introduction of the company's pipeline of tissue and organ implants.
Current Investors
Revolution Ventures, Better Ventures, KdT Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Biomaterials
Website
www.dimensioninx.com
Verticals
3D Printing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Dimension Inx, LLC - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.